SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 3/20/2017 10:34:35 AM - Followers: 33 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BMY News: Bristol-Myers Squibb & CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody™ Therapeutics for the Treatme... 03/20/2017 06:59:00 AM
BMY News: Bristol-Myers Squibb & Pfizer Present Large Real-World Observational Analysis of the Effectiveness & Safety of Direct Oral An... 03/17/2017 11:15:00 AM
BMY News: Bristol-Myers Squibb to Announce Results for First Quarter 2017 on April 27 03/10/2017 10:20:00 AM
BMY News: Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President and Chief Scientific Officer 03/08/2017 12:24:00 PM
BMY News: Bristol-Myers Squibb to Take Part in Barclays Global Health Care Conference 03/08/2017 09:00:00 AM
PostSubject
#421  Sticky Note Musings on 4Q16 results /2017 guidance: #msg-128169138. DewDiligence 01/26/17 12:27:05 PM
#472   BMY/CTMX expand 2014 collaboration: #msg-129678872. DewDiligence 03/20/17 10:34:34 AM
#471   More on the same subject (Eliquis): #msg-129664192. DewDiligence 03/19/17 05:54:12 PM
#470   Bristol-Myers Squibb and Pfizer Present Large Real-World Observational chmcnfunds 03/17/17 11:36:26 AM
#469   Bristol-Myers Squibb (BMY) Presents at Barclays Global Healthcare chmcnfunds 03/15/17 01:33:32 PM
#468   Jefferies Expects a Bristol-Myers Squibb Bounce chmcnfunds 03/09/17 10:36:44 AM
#467   Entire release: chmcnfunds 03/08/17 01:28:04 PM
#466   BMY hires MGH* doctor as CSO: DewDiligence 03/08/17 12:34:34 PM
#465   Bristol-Myers Squibb (BMY) CEO Giovanni Caforio Presents at chmcnfunds 03/06/17 04:10:59 PM
#464   Through my iHub app it had it listed Jaynes19 03/06/17 09:20:54 AM
#463   I see approximately 6000 additional shares, not 1,594,741. chmcnfunds 03/06/17 07:35:35 AM
#462   That 1,000,000 was just part of the trade. Jaynes19 03/04/17 12:09:05 PM
#461   Quite a trade AH: chmcnfunds 03/03/17 04:57:26 PM
#460   Best close in > 3 mo. Only 2nd chmcnfunds 03/03/17 04:05:10 PM
#459   Dividend remains at 0.39 chmcnfunds 03/02/17 04:40:20 PM
#458   Two notable insider transactions… DewDiligence 03/02/17 10:22:03 AM
#457   Bristol-Myers Squibb Expands Focus on Precision Medicine with chmcnfunds 03/01/17 08:16:38 AM
#456   Wrong board? DewDiligence 02/28/17 04:15:40 PM
#455   True Nature Expands Board, Appoints Senior Pharma Executive http://finance.yahoo goingforittoday 02/28/17 10:36:32 AM
#454   Bristol-Myers: Activist Investor Overload chmcnfunds 02/27/17 10:19:09 AM
#453   The interest rates look pretty attractive for BMY (#msg-128922451). DewDiligence 02/23/17 03:40:29 PM
#452   Bristol-Myers Squibb Co (NYSE:BMY) To Sell Senior Notes trendmkr 02/23/17 02:14:08 PM
#451   Bristol-Myers Looms as Pharma's Next Megadeal as Activists Join chmcnfunds 02/23/17 10:36:50 AM
#450   $1.5B bond issue to fund stock buyback (in part): DewDiligence 02/22/17 06:20:34 PM
#449   Schedule 13D is an SEC filing that must chmcnfunds 02/22/17 02:41:38 PM
#448   Maybe hit the $57.21 it spiked to yesterday: chmcnfunds 02/22/17 12:15:56 PM
#447   Nothing new, but context: chmcnfunds 02/22/17 07:24:20 AM
#446   WSJ reports Icahn has taken a stake -- chmcnfunds 02/21/17 03:43:45 PM
#445   JANA influence: chmcnfunds 02/21/17 08:22:26 AM
#444   Strange after-hours trade yesterday: chmcnfunds 02/17/17 08:04:21 AM
#443   Would Pfizer, Roche or Novartis megamerge with BMS? chmcnfunds 02/15/17 02:03:51 PM
#442   Chatter has legs: chmcnfunds 02/15/17 11:49:11 AM
#441   Could Gilead Really Buy Bristol-Myers Squibb? chmcnfunds 02/15/17 09:23:00 AM
#440   BMY, I am Long term, collecting divy's,(2.90%) while Norton1973 02/15/17 07:35:26 AM
#439   BMY, PFE… 05:43 chmcnfunds 02/15/17 07:31:49 AM
#438   I caught Bristol-Myers BMY, close to a 52 Norton1973 02/14/17 03:52:21 PM
#437   From SA: chmcnfunds 02/14/17 12:50:04 PM
#436   Take-over chatter causing a pop: chmcnfunds 02/14/17 12:10:45 PM
#435   Bit surprised since I believe folks generally have chmcnfunds 02/07/17 10:23:07 AM
#434   The Endpoints blog you posted has some misleading DewDiligence 02/07/17 09:42:30 AM
#433   Bristol-Myers partner Innate concedes a PhII flop for chmcnfunds 02/06/17 08:38:27 AM
#432   Bristol-Myers' Lirilumab Flunks Mid-Stage Study In Leukemia chmcnfunds 02/06/17 08:31:15 AM
#431   You’re correct (my bad). Keytruda sales for all DewDiligence 02/02/17 05:46:06 PM
#430   Nivolumab for Treatment of Urothelial Carcinoma chmcnfunds 02/02/17 02:26:11 PM
#429   Not actually if the chart figures are correct, chmcnfunds 02/02/17 12:13:20 PM
#428   As was mentioned on Twitter, Opdivo sales in DewDiligence 02/02/17 12:03:34 PM
#427   https://pbs.twimg.com/media/C3qGlZ4UYAQtU_2.jpg chmcnfunds 02/02/17 11:56:22 AM
#426   Merck Makes Nice With Bristol-Myers Squibb chmcnfunds 01/31/17 10:46:23 AM
#425   Bristol-Myers Squibb (BMY) Q4 2016 Results - Earnings chmcnfunds 01/30/17 10:33:50 AM
#424   WSJ’s Charley Grant agrees: DewDiligence 01/26/17 01:23:35 PM
#423   I've been in BMY for years. What mgt 2014shelby 01/26/17 01:06:37 PM
PostSubject